Drug–Drug, Drug–Disease and Disease–Disease Interactions in COVID-19 with Cardiovascular Diseases (CVDs)
Coronaviruses are a large family of single positive-stranded, enveloped RNA viruses that can infect many animal species and humans. Human coronaviruses can be divided based on their pathogenicity. Globally so far, over nine million people have tested COVID-19 positive, of which, 4, 25,000 are in Ind...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Thieme Medical and Scientific Publishers Pvt. Ltd.
2020-09-01
|
Series: | Indian Journal of Cardiovascular Disease in Women |
Subjects: | |
Online Access: | http://www.thieme-connect.de/DOI/DOI?10.1055/s-0040-1716786 |
id |
doaj-225c46bf0662496889970309937f8ec5 |
---|---|
record_format |
Article |
spelling |
doaj-225c46bf0662496889970309937f8ec52020-12-02T18:29:25ZengThieme Medical and Scientific Publishers Pvt. Ltd.Indian Journal of Cardiovascular Disease in Women2455-78542020-09-0150321622210.1055/s-0040-1716786Drug–Drug, Drug–Disease and Disease–Disease Interactions in COVID-19 with Cardiovascular Diseases (CVDs)M. Jyotsna0Y. Hemalatha1Department of Cardiology, Nizams Institute of Medical Sciences, Punjagutta, Hyderabad, Telangana, IndiaDepartment of Cardiology, Nizams Institute of Medical Sciences, Punjagutta, Hyderabad, Telangana, IndiaCoronaviruses are a large family of single positive-stranded, enveloped RNA viruses that can infect many animal species and humans. Human coronaviruses can be divided based on their pathogenicity. Globally so far, over nine million people have tested COVID-19 positive, of which, 4, 25,000 are in India. The FDA for the prevention or treatment of COVID-19 has approved no drugs or biologics. Numerous other antiviral agents, immunotherapies, and vaccines continue to be investigated and developed as potential therapies. Searching for effective therapies for COVID-19 infection is a complex process. The cardiovascular disease (CVD) drugs and the COVID-19 treating drugs show potent drug–drug interactions (DDI), disease–drug interactions, and disease–disease interactions.http://www.thieme-connect.de/DOI/DOI?10.1055/s-0040-1716786cardiovascular drugscovid-drugsinteractionspharmacotherapies |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
M. Jyotsna Y. Hemalatha |
spellingShingle |
M. Jyotsna Y. Hemalatha Drug–Drug, Drug–Disease and Disease–Disease Interactions in COVID-19 with Cardiovascular Diseases (CVDs) Indian Journal of Cardiovascular Disease in Women cardiovascular drugs covid-drugs interactions pharmacotherapies |
author_facet |
M. Jyotsna Y. Hemalatha |
author_sort |
M. Jyotsna |
title |
Drug–Drug, Drug–Disease and Disease–Disease Interactions in COVID-19 with Cardiovascular Diseases (CVDs) |
title_short |
Drug–Drug, Drug–Disease and Disease–Disease Interactions in COVID-19 with Cardiovascular Diseases (CVDs) |
title_full |
Drug–Drug, Drug–Disease and Disease–Disease Interactions in COVID-19 with Cardiovascular Diseases (CVDs) |
title_fullStr |
Drug–Drug, Drug–Disease and Disease–Disease Interactions in COVID-19 with Cardiovascular Diseases (CVDs) |
title_full_unstemmed |
Drug–Drug, Drug–Disease and Disease–Disease Interactions in COVID-19 with Cardiovascular Diseases (CVDs) |
title_sort |
drug–drug, drug–disease and disease–disease interactions in covid-19 with cardiovascular diseases (cvds) |
publisher |
Thieme Medical and Scientific Publishers Pvt. Ltd. |
series |
Indian Journal of Cardiovascular Disease in Women |
issn |
2455-7854 |
publishDate |
2020-09-01 |
description |
Coronaviruses are a large family of single positive-stranded, enveloped RNA viruses that can infect many animal species and humans. Human coronaviruses can be divided based on their pathogenicity. Globally so far, over nine million people have tested COVID-19 positive, of which, 4, 25,000 are in India. The FDA for the prevention or treatment of COVID-19 has approved no drugs or biologics. Numerous other antiviral agents, immunotherapies, and vaccines continue to be investigated and developed as potential therapies. Searching for effective therapies for COVID-19 infection is a complex process. The cardiovascular disease (CVD) drugs and the COVID-19 treating drugs show potent drug–drug interactions (DDI), disease–drug interactions, and disease–disease interactions. |
topic |
cardiovascular drugs covid-drugs interactions pharmacotherapies |
url |
http://www.thieme-connect.de/DOI/DOI?10.1055/s-0040-1716786 |
work_keys_str_mv |
AT mjyotsna drugdrugdrugdiseaseanddiseasediseaseinteractionsincovid19withcardiovasculardiseasescvds AT yhemalatha drugdrugdrugdiseaseanddiseasediseaseinteractionsincovid19withcardiovasculardiseasescvds |
_version_ |
1724403916593954816 |